Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Low-dose aspirin reduces cardiovascular events

16.11.2006
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized, according to a new analysis by Duke University Medical Center cardiologists.

The study also found that taking low-dose aspirin daily increases a patient's risk of bleeding, but the researchers said the protective benefits of aspirin outweigh this side effect. A daily dose of aspirin is considered low if it is between 81 milligrams and 325 milligrams.

"Among patients with stable cardiovascular disease, we found that low-dose aspirin reduced incidence of heart attack, stroke and death," said cardiology fellow Jeffrey Berger, M.D., who presented the results of the study on Wednesday, Nov. 15, at the annual scientific sessions of the American Heart Association, in Chicago.

"We also saw an increased risk of bleeding among patients taking aspirin, but as in the decision-making process involving any therapy, there is always the weighing of benefits and risks," Berger added. "Since a great majority of patients can tolerate aspirin, the benefits appear to outweigh the risks. Aspirin is a drug that has been used for many years. It is well-understood, effective, inexpensive and widely available. In aspirin we have a proven life-saver."

The study was supported by Duke's Division of Cardiology.

Aspirin exerts its protective effect by preventing the clumping together of platelets circulating in the blood, according to the researchers. It is this anticlotting action that also causes unwanted bleeding.

In the Duke study, Berger and colleagues combined the data from six clinical trials that enrolled patients with stable cardiovascular disease or stable angina, or chest pain, and gave them low-dose aspirin. In total, the trials included 9,853 patients.

The researchers found that patients who took low-dose aspirin had a 26 percent reduction in the risk of a nonfatal heart attack, a 25 percent reduction in the risk of stroke and a 13 percent reduction in risk of death, compared with similar heart patients who did not take aspirin. Taken together, Berger said, patients on low-dose aspirin had a 21 percent reduction in risk of experiencing a major cardiovascular event, a measurement that is the combination of the rates of nonfatal heart attack and stroke and of cardiovascular death.

In terms of aspirin's effect in promoting bleeding, the study found that one patient out of 111 who received low-dose aspirin experienced a bleeding episode, Berger said.

Putting the results another way, Berger said, the results suggest that treating 83 patients will prevent one nonfatal heart attack, treating 40 patients will prevent one stroke, treating 30 patients will prevent one major cardiovascular event and treating 71 patients will prevent one death.

"When compared to other medications that have been proven effective in preventing cardiovascular events, aspirin comes off looking very good," Berger said.

For example, 91 patients would need to be treated with ACE inhibitors to prevent one death, compared with 71 patients for aspirin, he said. ACE inhibitors dilate blood vessels, making it easier for the heart to pump blood. Ninety-one patients would need to be treated with the inhibitors to prevent one heart attack, compared with 83 for aspirin, and 167 would need to be treated with the inhibitors to prevent one stroke, compared with 40 patients with aspirin.

"These comparisons show that a cheap and inexpensive medicine like aspirin is just as good, if not better, than other expensive medicines," Berger said.

Still, there is room for improvement in aspirin therapy, he said. In particular, he said, more study is needed to identify what dosage in the low-dose range -- from 81 milligrams to 325 milligrams a day -- will provide the best benefit-to-risk profile.

Richard Merritt | EurekAlert!
Further information:
http://www.mc.duke.edu

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>